Drug and nutrient transfers through the blood-brain barrier and their pharmacological changes;Mecanismes de transfert a travers la barriere hemato-encephalique des nutriments et des medicaments et leurs modifications pharmacologiques

Encephale

Volumn 25, Issue 2, 1999, Pages 135-145

  Jolliet Riant, Pascale ^a   Tillement, J P ^a  

^a FACULTÉ DE MÉDECINE   (France)

Author keywords

Blood brain barrier; Brain delivery; Drug; Endothelial transporter; Nutrient

Indexed keywords

BRADYKININ; GLYCOPROTEIN P; INSULIN; MANNITOL; TRANSFERRIN; VITAMIN; AMINO ACID; DRUG DERIVATIVE; GLUCOSE; OSMOTIC DIURETIC AGENT;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FUNCTIONAL ANATOMY; GLUCOSE TRANSPORT; LIPOPHILICITY; NONHUMAN; PROTEIN TRANSPORT; BINDING SITE; BRAIN; CAPILLARY PERMEABILITY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

AMINO ACIDS; BINDING SITES; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN; CAPILLARY PERMEABILITY; DIURETICS, OSMOTIC; GLUCOSE; HUMANS; MANNITOL; P-GLYCOPROTEIN; VITAMINS;

EID: 0032967310     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AVELLINIL, TERRACINA L, GAITI A. Linoleic acid passage through the blood-brain barrier and a possible effect of age. Neurochem Res 1994 ; 19 : 129-33.
2. BANKS WA, KASTIN AJ. Passage of peptides across the blood-brain barrier : pathophysiological perspectives. Life Sci 1996 ; 59 : 1923-43.
3. BODOR N. Drug targeting and retrometabolic drug design approaches. Adv Drug Del Rev 1994 ; 14 : 157-66.
4. DEHOUCK MP, JOLLIET-RIANT P, BREE F et al. Drug transfer across the blood-brain barrier : correlation between in vitro and in vivo models. J Neurochem 1992 ; 58 : 1790-7.
5. DEHOUCK B, DEHOUCK MP, FRUCHART JC et al. Upregulation of the low density lipoprotein receptor at the blood-brain barrier : intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol 1994 ; 126 : 465-73.
6. DESCAMPS L, DEHOUCK MP, TORPIER G et al. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 1996 ; 270 : H1149-58.
7. DE VRIES HE, KUIPER J, DE BOER AG et al. The blood-brain barrier in neuroinflammatory diseases. Pharm Rev 1997 ; 48 : 143-55.
8. ERMISCH A, BRUST P, KRETZSCHMAR R et al. Peptides and blood-brain barrier transport. Physiol Rev 1993 ; 73 : 489-527.
9. GALLO JM. Delivery of anti-HIV nucleosides to the central nervous system. Adv Drug Delivery Rev 1994 ; 14 : 199-209.
10. GOLDSTEIN GW, BETZ AL. Recent advances in understanding brain capillary function. Ann Neurol 1986 ; 14 : 389-95.
11. GREIG NH, SONCRANT TT, SHETTY HU et al. Brain uptakes and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother Pharmacol 1990 ; 26 : 263-8.
12. JOLLIET P, SIMON N, BREE F et al. Blood-to-brain transfer of various oxicams : effects of plasma binding on their brain delivery. Pharm Res 1997 ; 14 : 650-6.
13. JOLLIET-RIANT P, BOUKEF MF, DUCHE JC et al. The genetic variant A of human alpha1-glycoprotein acid limits the blood-to-brain transfer of drugs it binds. Life Sci 1998 ; 62 : 219-26.
14. KANG YS, TERASAKI T, OHNISHI T et al. In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. J Pharmacobiodyn 1990 ; 13 : 353-60.
15. LARSSON HBW, STUBGAARD M, FREDERIKSEN JL et al. Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DPTA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990 ; 16 : 117-31.
16. OLDENDORF WH. Measurement of brain uptake of radiolabeled aminoacids, amines, and hexoses after arterial injection. Am J Physiol 1971 ; 221 : 1629-39.
17. OLDENDORF WH. The blood-brain barrier. Exp Eye Res 1977 ; Suppl : 177-90.
18. OUDARD S, MARIE JP, PUJADE LAURAINE E. Résistance à la chimiothérapie de type MDR en pratique clinique. Bull Cancer 1996 ; 83 : 609-18.
19. PARDRIDGE WM. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann N Y Acad Sci 1993 ; 692 : 126-37.
20. PARDRIDGE WM, LANDAW EM. Tracer kinetic model of blood-brain barier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis. J Clin Invest 1984 ; 74 : 745-52.
21. POLT R, PORRECA F, SZABO LZ et al. Glycopeptide enkephalin analogues produce analgesia in mice : evidence for penetration of the blood-brain barrier. Proc Nat Acad Sci USA 1994 ; 91 : 7114-8.
22. REINHARDT CA, GLOOR SM. Co-culture blood-brain barrier models and their use for pharmatoxicological screening. Toxicol in vitro 1997 ; 11 : 513-8.
23. RIANT P, URIEN S, ALBENGRES E et al. Effects of the binding of imipramine to erythrocytes and plasma proteins on its transport through the rat blood-brain barrier. J Neurochem 1988 ; 51 : 421-5.
24. RIANT P, BREE F, URIEN S et al. How chronically administered valproate increases chlordiazepoxide transfer through the blood-brain barrier. Fundam Clin Pharmacol 1990 ; 4 : 105-14.
25. SCHLOSSHAUER B. The blood-brain barrier : morphology, molecules, and neurothelin. Bioessays 1993 ; 15 : 341-6.
26. SPECTOR R. Fatty acid transport through the blood-brain barrier. J Neurochem 1988 ; 50 : 639-43.
27. TAKASATO Y, RAPOPORT SI, SMITH QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984 ; 247 : H484-93.
28. TILLEMENT JP, URIEN S, CHAUMET-RIFFAUD P et al. Blood binding and tissue uptake of drugs. Recent advances and perspectives. Fundam Clin Pharmacol 1988 ; 2 : 223-38.
29. TRIGUERO D, BUCIAK JB, PARDRIDGE WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990 ; 54 : 1882-8.
30. TSUJI A, SAHEKI A, TAMAI I et al. Transport mechanism of 3-hydroxy-methy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. J Pharmacol Exp Ther 1993 ; 267 : 1085-90.
31. VAN ASPEREN J, MAYER U, VAN TELLINGEN O et al. The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci 1997 ; 86 : 881-4.
32. VORBRODT AW, TROWBRIDGE RS. Aluminium induced alteration of surface anionic sites in cultures brain microvascular endothelial cells. Acta Neuropathol 1993 ; 86 : 371-7.
33. WALKER I, NICHOLLS D, IRWIN WJ et al. Drug delivery via active transport at the blood-brain barrier : affinity of a prodrug of phosphoformate for the large amino acid transporter. Int J Pharm 1994 ; 104 : 157-67.
34. YAMAZAKI M, FUKUOKA H, NAGATA H et al. Transport mechanism of an H1-antagonist at the blood-brain barrier : transport mechanism of mepyramine using the carotid injection technique. Biol Pharm Bull 1994 ; 17 : 676-9.